A Trial Evaluating TG4050 in Ovarian Carcinoma.

Clinical trial NCT03839524 · COMPLETED

Trial details

NCT number: NCT03839524
Sponsor: Transgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Carcinoma Fallopian Tube Cancer Peritoneal Carcinoma

Start date: 2019-12-09
Primary completion: 2024-10-08
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.